Melissa J. Durham, PharmD, MACM, APh, BCACP is an Associate Professor of Clinical Pharmacy and the Assistant Dean of Diversity, Equity, and Inclusion at the School of Pharmacy. She received her Doctor of Pharmacy degree then completed a residency in Community Pharmacy Practice, both at USC. She also holds a Master of Academic Medicine degree from the Keck School of Medicine of USC.
Areas of clinical expertise include ambulatory care practice and community pharmacy-based patient care programs and pain management. She is board-certified in Ambulatory Care Pharmacy by the Board of Pharmacy Specialties and has established a pharmacist-run pain medication management clinic at the USC Pain Center, where she precepts PharmD students as well as ambulatory care and community pharmacy practice residents.
At the School of Pharmacy, Dr. Durham coordinates courses and teaches in a variety of subject areas, including pain management and professional development. She has given numerous presentations and presented papers on the subjects of pain management, the U.S. Opioid Crisis, leadership, and health professional education.
In her role as Assistant Dean Dr. Durham leads the continual development and design of the School of Pharmacy Diversity, Equity, and Inclusion initiatives. She chairs the related School of Pharmacy Committee and represents the School to all University and external diversity, equity, and inclusion committees and functions.
Areas of Expertise (5)
Educational Interventional Research
Diversity, Equity, and Inclusion
Community Pharmacy Practice
Keck School of Medicine at University of Southern California: MACM, Master of Academic Medicine 2014
USC School of Pharmacy: PGY1 Residency, Community Pharmacy Practice 2008
USC School of Pharmacy: Pharm.D., Doctor of Pharmacy 2007
California State University - Long Beach: B.S., Biochemistry
California State University - Long Beach: B.A., Chemistry
Selected Media Appearances (1)
Pain relief without opioids? Yes, it's possible
Pain is a complex process that affects areas of the brain involved in sleep, motivation and emotion. Because the experience of pain is so far-reaching, doctors believe the best approach to pain management is a combination of therapy, mindset and medication. "If we really want to address the opioid crisis, we have to offer patients treatments that are as effective as opioids, but don't put them at risk of developing dependence," Durham says. "The most effective approach to pain management requires multiple disciplines, and almost always includes medications and psychological intervention."
Selected Articles (3)
Clinical Pharmacy Services in a Multidisciplinary Specialty Pain ClinicPain Practice
Maral Semerjian, Melissa J. Durham, Edith Mirzaian, Mimi Lou, Steven H. Richeimer
2018 To describe a model of clinical pharmacy services as part of a multidisciplinary specialty pain clinic by discussing 1) the role of a clinical pharmacist in a specialty setting, including clinical interventions implemented, and 2) how integration of a clinical pharmacist may translate into an improved patient care model for the management of chronic pain.
Topical Ketamine in the Treatment of Complex Regional Pain SyndromeInternational Journal of Pharmaceutical Compounding
Melissa J. Durham, Hovik S. Mekhjian, Jeffery A. Goad, Mimi Lou, Michelle Ding, Steven H. Richeimer
2018 The purpose of this study was to evaluate the effectiveness and adverse effects of topical ketamine in the treatment of complex regional pain syndrome. Retrospective charts were reviewed of patients 18 years or older diagnosed with complex regional pain syndrome and treated with topical ketamine during the study period of May 2006 to April 2013 in an academic medical center specialty pain clinic. Exclusion criteria consisted of subjects who 1) were treated with topical ketamine for pain syndromes other than complex regional pain syndrome, 2) initiated other pain therapies concurrently with topical ketamine, 3) had less than two documented visits, 4) began use of topical ketamine prior to the start of the study period, 5) were under 18 years of age. Subjects with ICD-9 diagnoses codes complex regional pain syndrome-1 or complex regional pain syndrome-2 were identified from encounter-based data and billing records. Data collected for each subject included demographics, description of complex regional pain syndrome, concurrent medications and medical conditions, type of ketamine compound prescribed, duration of therapy, side effects, reasons for discontinuation (if any), and pain scores (numerical pain rating scale; 0 to 10). Data were analyzed using descriptive statistics. Institutional Review Board approval was obtained prior to initiating the study. Sixteen subjects met the inclusion/exclusion criteria for the study, 69% of which were female with an average age of 46 years (range: 24 to 60). Subjects took an average of 3.7 other pain medications (range: 2 to 8), had an average of 2.7 other co-morbid pain conditions (range: 1 to 5), and 1.6 other co-morbid non-pain conditions (range: 0 to 4). Eight (50%) reported that their pain had improved, while 7 (44%) reported a worsening of pain. One reported no change in pain score. No subjects reported adverse effects. Based on the findings in this study, the use of topical ketamine in the treatment of complex regional pain syndrome shows promise due to the overall limited options available to treat this condition, as well as the favorable safety profile of topical agents. Future prospective controlled studies are needed to demonstrate a clear benefit.
The Anti-vaccine Movement: A Pharmacist’s ViewVaccinophobia and Vaccine Controversies of the 21st Century
Jeffery A. Goad, Melissa J. Durham
2013 Pharmacists are widely known as the most accessible health care providers, and are often called upon to serve as the liaison between other health care professionals, patients, and caregivers to facilitate communication, clarify purpose of therapy, and dispel myths and misconceptions. In the last decade, pharmacists have begun to play an integral role in the provision of vaccinations, and are uniquely positioned to educate the public about vaccines and the current evidence to support their safe use. Currently, all 50 states allow pharmacists to administer vaccines. There are barriers to the continuing expansion of pharmacists in this role, including turf wars with other health care providers, lack of public understanding/acceptance of the pharmacist in that role, lack of understanding regarding the education and training of pharmacists, and lack of structure for compensation of pharmacists from insurers. Nevertheless, pharmacists have demonstrated the ability to increase vaccination rates.